Remdesivir
CSIR-IICT initiatives to reduce dependency for APIs and drug intermediates
Active pharmaceutical ingredients (APIs) and intermediates are the key components of any drug that produces the intended effects. India is… Read More
Containing the Deadly COVID-19: Viability of Pooling Technologies
Global pandemic COVID-19 is now in 199 countries with reported confirmed cases above two million and mounting death tolls in… Read More
Gilead to Donate More than Million Doses of its Experimental Anti-Coronavirus Drug
Global pharma major Gilead is to donate 1.5 million doses of its experimental anti-coronavirus drug remdesivir, which could treat 140,000… Read More